1. There is no dose–response relationship between the amount of exercise and improvement in HbA1c in interventions over 12 weeks in patients with type 2 diabetes: a meta-analysis and meta-regression

   • Elizabeth Wrench
   • Kate Rattley
   • Christopher J. Gaffney

   Review Article Open access 05 August 2022 Pages: 1399 - 1415

   

2. Circulating β2 and α1 microglobulins predict progression of nephropathy in diabetic patients: a meta‐analysis of prospective cohort studies

   • Alieh Gholaminejad
   • Shiva Moein
   • Yousof Gheisari

   Review Article 08 August 2022 Pages: 1417 - 1427

   

3. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome

   • Gino Seravalle
   • Jennifer Vanoli
   • Guido Grassi

   Original Article Open access 29 July 2022 Pages: 1429 - 1435

   

4. Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists

   • Cristina Hernández
   • Fernando Gómez-Peralta
   • Rafael Simó

   Original Article 04 August 2022 Pages: 1437 - 1442

   

5. Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database

   • Wolfgang Rathmann
   • Karel Kostev

   Original Article Open access 06 August 2022 Pages: 1443 - 1451

   

6. A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes

   • Peter Bramlage
   • Sascha R. Tittel
   • Thomas Haak

   Original Article 07 August 2022 Pages: 1453 - 1460

   

7. Association of maternal diabetes during pregnancy with visual acuity development in offspring: a prospective cohort study

   • Qinwen Xu
   • Feng Zhang
   • Xujuan Xu

   Original Article 08 August 2022 Pages: 1461 - 1468

8. Gut microbial products valerate and caproate predict renal outcome among the patients with biopsy-confirmed diabetic nephropathy

   • Chenyu Zhong
   • Xu Bai
   • Kedan Cai

   Original Article 10 August 2022 Pages: 1469 - 1477

   

9. Not only for caregivers: intranasal glucagon for severe hypoglycaemia in a simulation study

   • A. Monzani
   • S. Savastio
   • I. Rabbone

   Original Article 11 August 2022 Pages: 1479 - 1484

   

10. Mortality after discharge from hospital following an episode of diabetic ketoacidosis

    • James A. D. Shand
    • Paul Morrow
    • Geoff Braatvedt

    Original Article 11 August 2022 Pages: 1485 - 1492

    

11. Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients

    • Anne Suhr Thykjær
    • N. Andersen
    • J. Grauslund

    Original Article Open access 12 August 2022 Pages: 1493 - 1503

    

12. Increased serum 12-hydroxyeicosatetraenoic acid levels are correlated with an increased risk of diabetic retinopathy in both children and adults with diabetes

    • Shuli Chen
    • Yu Qian
    • Haidong Zou

    Original Article Open access 12 August 2022 Pages: 1505 - 1513

    

13. Gestational diabetes mellitus and labor analgesia: nationwide register-based analysis in Finland

    • Ilari Kuitunen
    • Sakari Vähä-Tuisku
    • Tuomas Huttunen

    Short Communication Open access 02 August 2022 Pages: 1515 - 1517

    

14. Correction to: Association of glucose‑lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database

    • Wolfgang Rathmann
    • Karel Kostev

    Correction Open access 06 September 2022 Pages: 1519 - 1519